Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Chief Operating Officer | July 12, 2025 | July 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date July 12, 2025 · Filed July 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,362 |
Reported balance
After 2025-07-12 transaction · row 1
1 source rowRow 1 · 2025-07-12 · Tax withholding · Disposed 1,470 · Balance 42,362 F1: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 12, 2025 Filed Jul 15, 2025 23:06 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,470 | $23.95 | $35,206.50 |
DisclosureSEC source: 0001304492-25-000077 · wk-form4_1752620782.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,362 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 20, 2025 Filed May 22, 2025 19:20 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 53,491 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001304492-25-000040 · wk-form4_1747941609.xml · derivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,491 Underlying: Common Stock · 53,491 shares Expires 2035-05-20 F1 · derivative.exercise_date: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:35 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,383 | $28.42 | $39,304.86 |
DisclosureSEC source: 0001304492-25-000032 · wk-form4_1747776894.xml · nonDerivative · entry 2 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,832 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 15, 2025 Filed May 20, 2025 21:35 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,876 | $28.06 | $80,700.56 |
DisclosureSEC source: 0001304492-25-000032 · wk-form4_1747776894.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,215 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 22:24 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 67,774 | $0.00 Strike: $27.83 | $0.00 |
DisclosureSEC source: 0001304492-25-000008 · wk-form4_1737498291.xml · derivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,774 Underlying: Common Stock · 67,774 shares Expires 2035-01-16 F1 · derivative.exercise_date: The shares subject to this option vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 21:56 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 61,462 | $0.00 Strike: $35.66 | $0.00 |
DisclosureSEC source: 0001304492-24-000112 · wk-form4_1728424555.xml · derivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,462 Underlying: Common Stock · 61,462 shares Expires 2034-10-04 F1 · derivative.exercise_date: The option shares vest on the third anniversary of the grant date, subject to (i) the Reporting Person's continued service with the Issuer through this date and (ii) the Issuer's common stock achieving a specified price per share during the three-year period. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:39 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,479 | $41.51 | $61,393.29 |
DisclosureSEC source: 0001304492-24-000096 · wk-form4_1721075977.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,091 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 17, 2024 Filed May 21, 2024 18:11 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,391 | $33.52 | $46,626.32 |
DisclosureSEC source: 0001304492-24-000058 · wk-form4_1716315096.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,570 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 15, 2024 Filed May 18, 2024 01:59 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,867 | $32.72 | $93,808.24 |
DisclosureSEC source: 0001304492-24-000053 · wk-form4_1715997555.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,961 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 02:26 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $37.42 | $0.00 |
DisclosureSEC source: 0001304492-24-000026 · wk-form4_1709346376.xml · derivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: 8,000 of the option shares vest and become exercisable on May 22, 2024; 32,000 additional option shares vest and become exercisable on May 22, 2025; and the remaining 20,000 unvested option shares vest and become exercisable on May 22, 2026. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 12:35 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,456 | $37.76 | $92,738.56 |
DisclosureSEC source: 0001821509-24-000003 · wk-form4_1708432537.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,828 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 23:08 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 10,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-042310 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,284 F1 · shares: Represents the issuance of restricted stock units ("RSUs"). The RSUs vest and become exercisable in 3 equal annual installments beginning on July 12, 2024. Read SEC document |
| May 18, 2023 Filed May 22, 2023 22:49 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 4,282 | $31.11 | $133,213.02 |
DisclosureSEC source: 0001209191-23-031592 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,197 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:00 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,485 | $32.73 | $81,334.05 |
DisclosureSEC source: 0001209191-23-010858 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,479 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:33 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,898 | $42.47 | $123,078.06 |
DisclosureSEC source: 0001209191-22-033337 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,638 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:17 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 25,511 | $0.00 Strike: $49.39 | $0.00 |
DisclosureSEC source: 0001209191-22-030501 · doc4.xml · derivative · entry 2 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,511 Underlying: Common Stock · 25,511 shares Expires 2032-05-17 F2 · derivative.exercise_date: 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:17 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 12,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030501 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,536 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter. Read SEC document |
| February 17, 2022 Filed Jun 9, 2022 01:03 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,674 | $54.10 | $90,563.40 |
DisclosureSEC source: 0001209191-22-035271 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,964 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:46 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 26,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030681 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,881 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 5, 2022 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 05, 2021 Filed May 10, 2021 22:33 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 26,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031399 · doc4a.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,881 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. The prior Form 4 incorrectly reported that 25% of the RSUs vest and become exercisable on May 5, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 00:39 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 2,018 | $42.00 | $84,756.00 |
DisclosureSEC source: 0001209191-21-011525 · doc4.xml · nonDerivative · entry 1 Gerbrandt Ryan · CIK 0001821509 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,794 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.